RE:Re earningsMy guess is revenues will be somewhere between 90-100m. That figure is based on $5 wholesale price on their supply agreements, 25m rev from medical, 10-20m on supply agreements with ontario, plus private retail stores. That figure seems attainable considering their inventory stockpile. Also, there should be a significant rise in the unrealized gain of biological assets in the i/s for the purpose of increasing their stockpile of inventory to capture marketshare.
Bottomline figures is much difficult to asses primarily due to the convertible debt. But it was mentioned that their operating expenses should decrease.